Evidence map›Paper›PMID 32773758›Full record

ArticleJournal of visualized experiments : JoVE2020

In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography.

Rachael S Allen, Katie Bales, Andrew Feola, Machelle T Pardue

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pig Models in Retinal Research and Retinal Disease.Cold Spring Harbor perspectives in medicine · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rachael S AllenCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center; Department of Biomedical Engineering, Georgia Institute of Technology; restewa@emory.edu.
Katie BalesCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center; Department of Ophthalmology, Emory University.
Andrew FeolaCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center; Department of Biomedical Engineering, Georgia Institute of Technology.
Machelle T PardueCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center; Department of Biomedical Engineering, Georgia Institute of Technology; Department of Ophthalmology, Emory University.
Emory University · USGeorgia Institute of Technology · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)R01EY021592 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, IUVONE, P MICHAEL · 2013 to 2021
$3.3M
The RPE and Recovery of the Blood Retina BarrierR01EY028450 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, GROSSNIKLAUS, HANS E. · 2018 to 2022
$2.4M
Exercise-induced Retinal NeuroprotectionR01EY028859 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, PARDUE, MACHELLE T. · 2018 to 2021
$2.0M
Neuroprotective strategies for retinopathy and cognition in diabetesIK1RX002111 · VA · VETERANS HEALTH ADMINISTRATION · PI ALLEN, RACHAEL STEWART · 2016 to 2017
–
The Effect of Estrogen Deficiencies on Vision Loss in GlaucomaIK2RX002342 · VA · VETERANS HEALTH ADMINISTRATION · PI FEOLA, ANDREW J · 2018 to 2023
–
Dopamine treatments for diabetic retinopathyI01RX002615 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2018 to 2021
–
Neuroprotective strategies for retinopathy and cognition in diabetesIK2RX002928 · VA · VETERANS HEALTH ADMINISTRATION · PI ALLEN, RACHAEL STEWART · 2019 to 2023
–
RR&D Research Career Scientist Award ApplicationIK6RX003134 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2019 to 2025
–
NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY021592NEI NIH HHS R01 EY028450NEI NIH HHS R01 EY028859NEI NIH HHS T32 EY007092RRD VA I01 RX002615RRD VA I01 RX002806RRD VA IK1 RX002111RRD VA IK2 RX002342RRD VA IK2 RX002928RRD VA IK6 RX003134
6 · The paper itself

Abstract

Spectral-domain optical coherence tomography (SD-OCT) is useful for visualizing retinal and ocular structures in vivo. In research, SD-OCT is a valuable tool to evaluate and characterize changes in a variety of retinal and ocular disease and injury models. In light induced retinal degeneration models, SD-OCT can be used to track thinning of the photoreceptor layer over time. In glaucoma models, SD-OCT can be used to monitor decreased retinal nerve fiber layer and total retinal thickness and to observe optic nerve cupping after inducing ocular hypertension. In diabetic rodents, SD-OCT has helped researchers observe decreased total retinal thickness as well as decreased thickness of specific retinal layers, particularly the retinal nerve fiber layer with disease progression. In mouse models of myopia, SD-OCT can be used to evaluate axial parameters, such as axial length changes. Advantages of SD-OCT include in vivo imaging of ocular structures, the ability to quantitatively track changes in ocular dimensions over time, and its rapid scanning speed and high resolution. Here, we detail the methods of SD-OCT and show examples of its use in our laboratory in models of retinal degeneration, glaucoma, diabetic retinopathy, and myopia. Methods include anesthesia, SD-OCT imaging, and processing of the images for thickness measurements.

Indexed as

Tomography, Optical CoherenceAnimalsAxial Length, EyeDisease Models, AnimalEyeEye DiseasesFemaleImage Processing, Computer-AssistedMaleMice, Inbred BALB CMyopiaPhotoreceptor Cells, VertebrateRatsRetina

Identifiers

PMID32773758
PMCPMC7949486
OpenAlexW3044033155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.